Written Ministerial Statement:
Cervical screening for women aged under 25 years

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Cervical Screening Annual Review
Cervical Screening Statistics

Research Literature Online Database

Published 24th June, 2009

DEPARTMENT OF HEALTH

Cervical screening for women aged under 25 years

Wednesday 24th June 2009

The Parliamentary Under-Secretary of State, Department of Health (Ann Keen): I announced in my Written Ministerial Statement of 13th March 2009 that we had asked the independent Advisory Committee on Cervical Screening (ACCS) to formally review the evidence relating to risks and benefits of cervical screening in women under 25 years, including current evidence regarding incidence and mortality in young women.

The review took place at an extraordinary meeting of the ACCS held on 19th May 2009. The ACCS is an independent ministerially appointed committee, with most members nominated by their respective professional bodies. A number of guests were also invited to the review meeting to ensure all opinions and available evidence were heard, including the voluntary sector and patients.

No new scientific evidence was presented to the review meeting to support the reintroduction of screening in women under 25. Indeed some new evidence was presented indicating that screening is of little or no benefit in women in this age group. There is evidence that treatment following screening in this age group can lead to an increased risk of subsequent premature births, increasing the risk of babies dying or having severe disabilities. Evidence was also presented that showed there has been no significant increase in the number of women aged under 25 contracting or dying from cervical cancer since the policy change in 2004.

Members of the committee were unanimous that there was no reason to lower the age at which screening commences, which is in line with international recommendations.

Members of the committee were, however, concerned that young women who present to their GPs with gynaecological symptoms are not always being given appropriate advice. They strongly recommended that the Department of Health should take further action in this area, and the ACCS will be considering how best to take this forward as a matter of urgency at their meeting on 25th June 2009. Members also recommended that more effort is made in increasing the uptake of cervical screening in women aged 25 to 34, where coverage has been falling in recent years. We will develop plans with NHS Cancer Screening Programmes and the National Awareness and Early Diagnosis Initiative to take this forward.

The committee will keep the decision closely under review, especially by monitoring the incidence of cervical cancer in young women. In the interests of transparency, the minutes of the review meeting have been placed in the House of Commons Library and will be made available on the Department of Health website.


Search this site for:
Cervical Screening Publications

Cervical screening programme index

What happens at a
screening appointment?

Cervical cancer

Diethylstilbestrol (DES) exposed women

Liquid Based Cytology (LBC)

LBC implementation guidance

Who does what in the NHS Cervical Screening Programme

Frequently Asked Questions (FAQs)

Quality assurance

Programme statistics

Archived statistics bulletins

Cytology training

Human Papilloma Virus (HPV)

HPV Sentinel Sites

HMR 101 guidance notes

Research

Useful links

Publications

Programme posters

Archive

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

cervical/news/012.html
Designed and hosted by The Net Effect

This page validates to HTML 4.0This document validates as CSS!
©NHS Cancer Screening Programmes